Should the surgeon or the general practitioner (GP) follow up patients after surgery for colon cancer? A randomized controlled trial protocol focusing on quality of life, cost-effectiveness and serious clinical events

[1] Svensson E(2002)Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis Eur J Cancer Prev 11 489-495

[2] Grotmol T(2004)Colorectal cancer survival trends in Norway 1958–1997 European Journal of Cancer 40 734-742

[3] Hoff G(1994)Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy Br J Surg 81 7-19

[4] Langmark F(1998)Realism or nihilism in bowel cancer follow-up? Lancet 351 1074-1076

[5] Norstein J(2002)Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials Bmj 324 813-423

[6] Tretli S(2002)Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial Eur J Surg Oncol 28 418-8670

[7] Angell-Andersen E(2005)Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials J Clin Oncol 23 8664-8519

[8] Tretli S(2005)Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline J Clin Oncol 23 8512-376

[9] Coleman MP(1993)The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365-1148

[10] Langmark F(1995)Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons Bmj 311 1145-567

[1] Svensson E(2002)Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis Eur J Cancer Prev 11 489-495

[2] Grotmol T(2004)Colorectal cancer survival trends in Norway 1958–1997 European Journal of Cancer 40 734-742

[3] Hoff G(1994)Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy Br J Surg 81 7-19

[4] Langmark F(1998)Realism or nihilism in bowel cancer follow-up? Lancet 351 1074-1076

[5] Norstein J(2002)Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials Bmj 324 813-423

[6] Tretli S(2002)Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial Eur J Surg Oncol 28 418-8670

[7] Angell-Andersen E(2005)Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials J Clin Oncol 23 8664-8519

[8] Tretli S(2005)Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline J Clin Oncol 23 8512-376

[9] Coleman MP(1993)The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365-1148

[10] Langmark F(1995)Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons Bmj 311 1145-567